Should an early switch to intravitreal steroids be considered in DME patients with a suboptimal response to anti-VEGF therapy?

Click here to view the Cover Story to this Point/Counter.

There are now sufficient data to show that switching early makes sense if a patient does not respond adequately to anti-VEGF therapy. My recommendation is to switch between three and five injections and not wait longer if the signs of inadequate response are there. In addition to central retinal thickness, there are several other parameters to evaluate that are specific for DME because they are related to inflammation. OCT technology is now able to look at the retina in great (Read more...)

Full Story →